Drug shortage
Amoxicillin Powder · Hikma Pharmaceuticals USA, Inc.
FDA drug shortage · Resolved · updated May 2, 2025
Key facts
| Generic name | Amoxicillin Powder, For Suspension |
|---|---|
| Company | Hikma Pharmaceuticals USA, Inc. |
| Presentation | Amoxicillin, Powder, For Suspension, 400 mg/5 mL (NDC 0143-9887-50) |
| Dosage form | For Suspension, Powder |
| Status | Resolved |
| Therapeutic category | Anti-Infective Pediatric |
| Package NDCs | 0143-9887-50 |
| First posted | Oct 28, 2022 |
| Last updated | May 2, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: